Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Tao, Ran ^a   Li, Jun ^a   Xin, Jiaojiao ^a   Wu, Jian ^a   Guo, Jing ^a   Zhang, Liyuan ^a   Jiang, Longyan ^a   Zhang, Wu ^a   Yang, Zhe ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; VIRUS DNA; MESSENGER RNA; TUMOR MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; EMILIN2 GENE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GRASP GENE; HEPATITIS B VIRUS; HIST1H4F GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; MALE; RESTRICTION MAPPING; TLX3 GENE; TM6SF1 GENE; TRIM58 GENE; TUMOR GENE; WNK2 GENE; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HEPATITIS B; HUMAN GENOME; LIVER; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

HEPATITIS B VIRUS;

ADULT; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; DNA METHYLATION; GENE EXPRESSION PROFILING; GENOME, HUMAN; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 79956368802     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019862     Document Type: Article

References (49)

1. Blumberg BS, (2010) Primary and secondary prevention of liver cancer caused by HBV. Front Biosci (Schol Ed) 2: 756-763.
2. Shi YH, Ding WX, Zhou J, He JY, Xu Y, et al. (2008) Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence. Hepatology 48: 497-507.
3. Wu LM, Yang Z, Zhou L, Zhang F, Xie HY, et al. (2010) Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma. PLoS One 5: e14460.
4. Zhong S, Tang MW, Yeo W, Liu C, Lo YM, et al. (2002) Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clinical Cancer Research 8: 1087-1092.
5. Moribe T, Iizuka N, Miura T, Kimura N, Tamatsukuri S, et al. (2009) Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. International Journal of Cancer 125: 388-397.
6. Lou C, Du Z, Yang B, Gao Y, Wang Y, et al. (2009) Aberrant DNA methylation profile of hepatocellular carcinoma and surgically resected margin. Cancer Sci 100: 996-1004.
7. Li B, Liu W, Wang L, Li M, Wang J, et al. (2010) CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma. Ann Surg Oncol 17: 1917-1926.
8. Um TH, Kim H, Oh BK, Kim MS, Kim KS, et al. (2010) Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. Journal of Hepatology.
9. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, et al. (2008) Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135: 2128-2140, 2140 e2121-2128.
10. Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, et al. (2008) Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis 29: 1901-1910.
11. Deng YB, Nagae G, Midorikawa Y, Yagi K, Tsutsumi S, et al. (2010) Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. Cancer Sci 101: 1501-1510.
12. Archer KJ, Mas VR, Maluf DG, Fisher RA, (2010) High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. Mol Genet Genomics 283: 341-349.
13. Lambert MP, Paliwal A, Vaissiere T, Chemin I, Zoulim F, et al. (2010) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. Journal of Hepatology.
14. Bhowmick NA, Neilson EG, Moses HL, (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337.
15. Harrell JC, Dye WW, Harvell DM, Sartorius CA, Horwitz KB, (2008) Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases. Clin Exp Metastasis 25: 81-88.
16. Waanders LF, Chwalek K, Monetti M, Kumar C, Lammert E, et al. (2009) Quantitative proteomic analysis of single pancreatic islets. Proc Natl Acad Sci U S A 106: 18902-18907.
17. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, et al. (2006) Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 98: 255-261.
18. Ai J, Tan Y, Ying W, Hong Y, Liu S, et al. (2006) Proteome analysis of hepatocellular carcinoma by laser capture microdissection. Proteomics 6: 538-546.
19. Guedj N, Dargere D, Degos F, Janneau JL, Vidaud D, et al. (2006) Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. Laboratory Investigation 86: 951-958.
20. Rescan PY, Clement B, Yamada Y, Segui-Real B, Baffet G, et al. (1990) Differential expression of laminin chains and receptor (LBP-32) in fetal and neoplastic hepatocytes compared to normal adult hepatocytes in vivo and in culture. American Journal of Pathology 137: 701-709.
21. Lee CF, Ling ZQ, Zhao T, Fang SH, Chang WC, et al. (2009) Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. World J Gastroenterol 15: 356-365.
22. Galli A, Ceni E, Mello T, Polvani S, Tarocchi M, et al. (2010) Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. Hepatology 52: 493-505.
23. Jeong JS, Lee SH, Jung KJ, Choi YC, Park WY, et al. (2003) Hepatotoxin N-nitrosomorpholine-induced carcinogenesis in rat liver: ex vivo exploration of preneoplastic and neoplastic hepatocytes. Exp Mol Pathol 74: 74-83.
24. Yamaji S, Zhang M, Zhang J, Endo Y, Bibikova E, et al. (2010) Hepatocyte-specific deletion of DDB1 induces liver regeneration and tumorigenesis. Proc Natl Acad Sci U S A 107: 22237-22242.
25. Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, et al. (2010) Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS One 5: e9749.
26. Tischoff I, Markwarth A, Witzigmann H, Uhlmann D, Hauss J, et al. (2005) Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors. International Journal of Cancer 115: 684-689.
27. Yuan Y, Wang J, Li J, Wang L, Li M, et al. (2006) Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clinical Cancer Research 12: 6687-6695.
28. Calvisi DF, Ladu S, Conner EA, Seo D, Hsieh JT, et al. (2011) Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. Journal of Hepatology 54: 311-319.
29. Qiu GH, Salto-Tellez M, Ross JA, Yeo W, Cui Y, et al. (2008) The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle. Journal of Hepatology 48: 433-441.
30. Li J, Tao R, Wu W, Cao H, Xin J, et al. (2010) Transcriptional profiling and hepatogenic potential of acute hepatic failure-derived bone marrow mesenchymal stem cells. Differentiation 80: 166-174.
31. Li J, Li L, Yu H, Cao H, Gao C, et al. (2006) Growth and metabolism of human hepatocytes on biomodified collagen poly(lactic-co-glycolic acid) three-dimensional scaffold. ASAIO J 52: 321-327.
32. Yang ZF, Lau CK, Ngai P, Lam SP, Ho DW, et al. (2008) Cardiotrophin-1 enhances regeneration of cirrhotic liver remnant after hepatectomy through promotion of angiogenesis and cell proliferation. Liver Int 28: 622-631.
33. Gerlyng P, Grotmol T, Erikstein B, Stokke T, Seglen PO, (1992) Reduced proliferative activity of polyploid cells in primary hepatocellular carcinoma. Carcinogenesis 13: 1795-1801.
34. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, et al. (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Human Molecular Genetics 10: 1413-1419.
35. Ma XD, Sui YF, Wang WL, (2000) Expression of gap junction genes connexin 32, connexin 43 and their proteins in hepatocellular carcinoma and normal liver tissues. World J Gastroenterol 6: 66-69.
36. Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M, (2009) Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 11: 323-338.
37. Zhang W, Couldwell WT, Song H, Takano T, Lin JH, et al. (2000) Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Research 60: 5395-5400.
38. Capiod T, Shuba Y, Skryma R, Prevarskaya N, (2007) Calcium signalling and cancer cell growth. Subcell Biochem 45: 405-427.
39. Fabregat I, (2009) Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol 15: 513-520.
40. Ljunggren HG, Malmberg KJ, (2007) Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7: 329-339.
41. Hong C, Moorefield KS, Jun P, Aldape KD, Kharbanda S, et al. (2007) Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth. Proc Natl Acad Sci U S A 104: 10974-10979.
42. Hill VK, Hesson LB, Dansranjavin T, Dallol A, Bieche I, et al. (2010) Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer 9: 51.
43. Wang Y, Yu Q, Cho AH, Rondeau G, Welsh J, et al. (2005) Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7: 748-760.
44. Slaughter DP, Southwick HW, Smejkal W, (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968.
45. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
46. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
47. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
48. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
49. Zhang B, Kirov S, Snoddy J, (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748.